Summary of Key Information:
Reporting Period (Quarter/Year): Quarter ended 30th June 2026 (Q1 FY27)
Nature of Filing / Announcement: Outcome of Board Meeting - Financial Results and Director Appointment
Audit Opinion:
Unmodified report issued by statutory auditors JV SL & Associates, Chartered Accountants (Firm Regn. No. 001002S)
No qualifications or modifications to the financial results
Key Financial Highlights [₹ in Lakhs]:
Standalone Results:
Revenue from Operations: ₹1,756.52 (Q1 FY27) vs ₹2,061.13 (Q1 FY26) - 14.8% decrease YoY
Total Income: ₹1,833.92 (Q1 FY27) vs ₹2,064.99 (Q1 FY26)
Other Income: ₹77.40 (Q1 FY27) vs ₹3.86 (Q1 FY26)
Expenses Breakdown:
Cost of Material Consumed: ₹1,391.98
Change in Inventories: -₹600.58
Employees benefit expense: ₹329.49
Finance cost: ₹37.45
Depreciation: ₹70.10
Power & Fuel: ₹224.60
Repairs & Maintenance: ₹36.31
Manufacturing Expenses: ₹114.67
R & D Expenditure: ₹37.78
Administrative, Marketing and Other Expenses: ₹256.54
Total Expenses: ₹1,898.34
Profit/(Loss) from Operations before Exceptional Items and Tax: -₹64.42 (Q1 FY27) vs ₹32.16 (Q1 FY26)
Exceptional Items: None
Profit/(Loss) from Continuing Operations before tax: -₹64.42
Tax expense: None for current quarter
Net Profit/(Loss) from Continuing Operations after tax: -₹64.42 (Q1 FY27) vs -₹115.30 (Q1 FY26)
Other Comprehensive Income: Not specified for current quarter
Total Comprehensive Income: -₹64.42
Paid-up equity share capital: ₹1,018.25 (Face Value ₹10 per share)
Reserves: Not specified for current quarter
Earnings per Share (₹10 face value, not annualized):
Basic: -₹0.63 (Q1 FY27) vs -₹1.13 (Q1 FY26)
Diluted: -₹0.63 (Q1 FY27) vs -₹1.13 (Q1 FY26)
Consolidated Results:
Not Specified
Segment-wise Performance:
The company has identified Geographical segments based on location of customers as reportable segments
Revenue Breakdown:
Domestic: ₹1,119.79 (Q1 FY27) vs ₹941.91 (Q1 FY26)
Export: ₹636.73 (Q1 FY27) vs ₹1,119.22 (Q1 FY26)
Total: ₹1,756.52
Trade Receivables:
Domestic: ₹562.82 (Q1 FY27) vs ₹280.62 (Q1 FY26)
Export: ₹839.30 (Q1 FY27) vs ₹705.78 (Q1 FY26)
Total: ₹1,402.12 (Q1 FY27) vs ₹986.40 (Q1 FY26)
Corporate Actions:
No dividends, buybacks, or capital structure changes declared
Other Significant Information:
The company manufactures: Sodium Amide, Sodium Alkoxides, Sodium Hydride, Sodium Azide, Tetrazoles, Amino Pyridines, Pyridine Derivatives, Cyclic Compounds, Fine Chemicals, Intermediates for pharmaceuticals and Active Pharmaceutical Ingredients
ISO 9001 & 14001 accredited company
Figures for quarter ended 31 March 2026 are balancing figures between audited full year figures and unaudited nine months figures
Previous period figures regrouped/rearranged for comparability